Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Erasca, Inc.

Clinical trials sponsored by Erasca, Inc., explained in plain language.

Erasca, Inc. ERAS NASDAQ

A clinical-stage biotech company developing precision oncology therapies.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet finished but already full! 4 Completed 1

New drug cocktail targets Hard-to-Treat gut cancers

Disease control Completed

This study tested a new cancer drug called ERAS-007, given by mouth, together with other targeted therapies in 101 people with advanced colorectal or pancreatic cancers that have certain gene changes. The main goals were to check safety, find the best dose, and see how the drugs …

Phase: PHASE1, PHASE2 • Sponsor: Erasca, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:00 UTC